Study uncovers clue to deciphering schizophrenia

June 7, 2016, Michigan State University
Credit: Michigan State University

The brains of healthy relatives of people with schizophrenia may hold a clue to better understand - and ultimately treat - the devastating illness, finds new research led by a Michigan State University scientist.

The study is the first to look at the neurotransmitters glutamate and gamma-aminobutyric acidergic, or GABA, in both and healthy relatives of schizophrenia patients using a noninvasive imaging test called .

Glutamate, which promotes the firing of brain cells, and GABA, which inhibits neural firing, work hand in hand to regulate brain function. In the past 20 years, many researchers have come to believe that glutamate and GABA play a role in schizophrenia, yet the precise relationship remains unclear and no medication for schizophrenia has hit the market specifically targeting these neurotransmitters.

According to the study, both schizophrenia patients and healthy relatives showed reduced levels of glutamate. But while the patients also showed reduced levels of GABA, the relatives had normal amounts of the inhibitory neurotransmitter.

This begs two key questions. First, if glutamate is altered, why do these relatives not show symptoms of the illness? And, second, how did healthy relatives maintain normal levels of GABA even though they, like the patients, were genetically predisposed to schizophrenia and had altered ?

"This finding is what's most exciting about our study," said lead investigator Katharine Thakkar, MSU assistant professor of clinical psychology. "It hints at what kinds of things have to go wrong for someone to express this vulnerability toward schizophrenia. The study gives us more specific clues into what kinds of systems we want to tackle when we're developing new treatments for this very devastating illness."

The research, reported online in the journal Biological Psychiatry, involved 21 patients with , 23 healthy relatives (the relatives were siblings of other patients with schizophrenia, not the patients in the study) and a control group of 24 healthy nonrelatives. It was performed in collaboration with researchers at the University Medical Center Utrecht in the Netherlands, where Thakkar served as a postdoctoral fellow.

Schizophrenia, which affects about 3.5 million Americans, is marked by delusions, hallucinations and other symptoms, although it is not, contrary to popular belief, split or multiple personality.

Many regulate dopamine, another neurotransmitter in the brain, though the medication does not work for everyone. In fact, medication for has changed very little in the past 50 years and remains somewhat limited in its effectiveness. Many researchers believe there are multiple risk factors for the illness, including dopamine and glutamate/GABA imbalance.

The brain scan used in the study - which is conducted on a conventional MRI machine - could eventually help clinicians target more specific treatments.

"There are likely different causes of the different symptoms and possibly different mechanisms of the illness across individuals," Thakkar said. "In the future, as this imaging technique becomes more refined, it could conceivably be used to guide individual treatment recommendations. That is, this technique might indicate that one individual would benefit more from treatment A and another individual would benefit more from treatment B, when these different treatments have different mechanisms of action."

Explore further: New schizophrenia treatments may be effective for subgroup of patients

Related Stories

New schizophrenia treatments may be effective for subgroup of patients

December 8, 2015
Mounting evidence indicates that disturbances in the brain's glutamate pathway contribute to symptoms of schizophrenia. Thus, the glutamate pathway has become the target of a number of new drug therapies. Findings published ...

Structural brain connectivity as a genetic marker for schizophrenia

November 25, 2015
Schizophrenia has been considered an illness of disrupted brain connectivity since its earliest descriptions. Several studies have suggested brain white matter is affected not only in patients with schizophrenia but also ...

Imaging study shows promising results for patients with schizophrenia

May 27, 2016
A team of scientists from across the globe have shown that the brains of patients with schizophrenia have the capacity to reorganize and fight the illness. This is the first time that imaging data has been used to show that ...

Study finds brain marker of poor memory in schizophrenia patients

April 4, 2016
A new study has identified a pattern of brain activity that may be a sign of memory problems in people with schizophrenia. The biomarker, which the researchers believe may be the first of its kind, is an important step toward ...

Discovery of the characteristics of subcortical regions in schizophrenia

March 18, 2016
A Japanese research group found that patients with schizophrenia demonstrated a specific leftward volumetric asymmetry for the globus pallidus, one of the basal ganglia of the brain. The basal ganglia are involved in motivation ...

How depression and antidepressant drugs work

May 18, 2016
New research demonstrates the effectiveness of ketamine to treat depression in a mouse model of the disease and brings together two hypotheses for the cause of depression. The research, led by Bernhard Lüscher, professor ...

Recommended for you

Mind wandering is fine in some situations, study says

June 20, 2018
It's a common experience for most students. You're sitting in a lecture that covers material you already know, and before long your mind drifts and you become occupied with thoughts of what you'll do over the weekend, or ...

Around the world, people have surprisingly modest notions of the 'ideal' life

June 20, 2018
It seems reasonable that people would want to maximize various aspects of life if they were given the opportunity to do so, whether it's the pleasure they feel, how intelligent they are, or how much personal freedom they ...

Say cheese! Why a toothy smile makes it easier for you to be identified

June 19, 2018
A fulsome smile in a photo makes it easier for people to identify the individual, say researchers at the University of York.

Genes associated with infantile forms of schizophrenia identified

June 19, 2018
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) and McGill University have identified novel genes associated with a specific form of schizophrenia.

Kids grasp that you get what you pay for

June 19, 2018
From a young age, children have a nuanced understanding of fairness.

Mental health declining among disadvantaged American adults

June 19, 2018
American adults of low socioeconomic status report increasing mental distress and worsening well-being, according to a new study by Princeton University and Georgetown University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.